Tamer Yagci
Tamer Yagci
Unknown affiliation
Verified email at gyte.edu.tr
Title
Cited by
Cited by
Year
SIP1 protein protects cells from DNA damage-induced apoptosis and has independent prognostic value in bladder cancer
AE Sayan, TR Griffiths, R Pal, GJ Browne, A Ruddick, T Yagci, R Edwards, ...
Proceedings of the National Academy of Sciences 106 (35), 14884-14889, 2009
1932009
Reprogramming of replicative senescence in hepatocellular carcinoma-derived cells
N Ozturk, E Erdal, M Mumcuoglu, KC Akcali, O Yalcin, S Senturk, ...
Proceedings of the National Academy of Sciences 103 (7), 2178-2183, 2006
782006
Quantification of SLIT-ROBO transcripts in hepatocellular carcinoma reveals two groups of genes with coordinate expression
ME Avci, O Konu, T Yagci
BMC cancer 8 (1), 1-11, 2008
482008
Novel monoclonal antibodies detect Smad-interacting protein 1 (SIP1) in the cytoplasm of human cells from multiple tumor tissue arrays
E Oztas, ME Avci, A Ozcan, AE Sayan, E Tulchinsky, T Yagci
Experimental and molecular pathology 89 (2), 182-189, 2010
452010
Novel anti-HER2 monoclonal antibodies: synergy and antagonism with tumor necrosis factor-α
C Ceran, M Cokol, S Cingoz, I Tasan, M Ozturk, T Yagci
BMC cancer 12 (1), 1-16, 2012
382012
SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation
T Acun, E Oztas, T Yagci, MC Yakicier
BMC cancer 11 (1), 1-10, 2011
332011
Germline hMSH2and hMLH1 gene mutations in incomplete HNPCC families
Q Wang, F Desseigne, C Lasset, JC Saurin, C Navarro, T Yagci, I Keser, ...
International journal of cancer 73 (6), 831-836, 1997
251997
Cancer stem cells in hepatocellular carcinoma
T Yagci, M Cetin, PB Ercin
Journal of gastrointestinal cancer 48 (3), 241-245, 2017
162017
Assessment of nuclear ZEB2 as a biomarker for colorectal cancer outcome and TNM risk stratification
R Sreekumar, S Harris, K Moutasim, R DeMateos, A Patel, K Emo, ...
JAMA network open 1 (6), e183115-e183115, 2018
132018
ETS1 is coexpressed with ZEB2 and mediates ZEB2‐induced epithelial‐mesenchymal transition in human tumors
I Yalim‐Camci, P Balcik‐Ercin, M Cetin, G Odabas, N Tokay, AE Sayan, ...
Molecular carcinogenesis 58 (6), 1068-1081, 2019
122019
Sulfatide mediates attachment of Pseudomonas aeruginosa to human pharyngeal epithelial cells
A Yagci, T Yagci, B Sener, Y Suziki, K Ahmed
New Microbiologica 30 (2), 167-171, 2007
122007
ROR1 expression and its functional significance in hepatocellular carcinoma cells
M Cetin, G Odabas, LR Douglas, PJ Duriez, P Balcik-Ercin, I Yalim-Camci, ...
Cells 8 (3), 210, 2019
112019
A monoclonal antibody against DNA binding helix of p53 protein
E Yolcu, BS Sayan, T Yağci, R Cetin-Atalay, T Soussi, N Yurdusev, ...
Oncogene 20 (11), 1398-1401, 2001
112001
Genomic instability in colorectal cancers in Turkey
T Yağci, S Göksel, Ö Doğan, M Ozturk, N Yurdusev
International journal of cancer 68 (3), 291-294, 1996
101996
Immunologic status in children with brain tumors and the effect of therapy
R Kebudi, I Ayan, E Darendeliler, L Agaoglu, S Ekmekçioglu, T Yagci, ...
Journal of neuro-oncology 24 (3), 219-227, 1995
101995
Genome-wide analysis of endogenously expressed ZEB2 binding sites reveals inverse correlations between ZEB2 and GalNAc-transferase GALNT3 in human tumors
P Balcik-Ercin, M Cetin, I Yalim-Camci, G Odabas, N Tokay, AE Sayan, ...
Cellular Oncology 41 (4), 379-393, 2018
92018
Plexin C1 marks liver cancer cells with epithelial phenotype and is overexpressed in hepatocellular carcinoma
G Odabas, M Cetin, S Turhal, H Baloglu, AE Sayan, T Yagci
Canadian Journal of Gastroenterology and Hepatology 2018, 2018
72018
Immunization with UV-induced apoptotic cells generates monoclonal antibodies against proteins differentially expressed in hepatocellular carcinoma cell lines
H Celikkaya, C Ciraci, E Oztas, ME Avci, M Ozturk, T Yagci
Hybridoma 26 (2), 55-61, 2007
52007
Hepatocellular Carcinoma Cells with Downregulated ZEB2 Become Resistant to Resveratrol by Concomitant Induction of ABCG2 Expression
P Balcik-Ercin, M Cetin, I Yalim-Camci, T Uygur, T Yagci
Molecular Biology 54 (1), 75-81, 2020
22020
Behavior of HepG2 liver cancer cells using microfluidic-microscopy: A preliminary study
H Karamahmutoglu, M Çetin, T Yağcı, M Elitaş
Microfluidics, BioMEMS, and Medical Microsystems XVI 10491, 104910Y, 2018
22018
The system can't perform the operation now. Try again later.
Articles 1–20